PHARMACEUTICAL IP

Evolve Insights

Welcome to Evolve Insights!

Evolve Insights is your go-to source for expert analysis and strategic perspectives on pharmaceutical IP.

  • Read our Articles for the latest pharma IP news and analysis. Many of our articles were originally published on IPKat.
  • Register for our upcoming live Webinars and watch our previous webinars on-demand.
  • Subscribe to our newsletter to stay up to date.

Do you have questions about how the latest developments in IP might impact you? Our team of experts would love to hear from you.

Latest articles

All articles

AI in the patent industry: Don’t believe the hype. Believe the data.

Many in the IP profession remain considerably sceptical of AI. AI may be useful for checking for typos and simple calculations of deadlines, but it cannot replace in-depth human reasoning about complex scientific and legal issues. However, the data suggests something different.

Popper: The global patent prosecution AI for pharmaceutical IP

Popper is Evolve’s proprietary AI tool, built by our own pharma patent attorneys to navigate the complex intersection of life sciences, global patent law, and commercial strategy.

Sequence identities and functional definitions – where is the limit? (T 0137/24)

Biotechnology patents often rely on defining protein and nucleic acid features by their sequence identity. However, it is often not necessary to define the exact sequence, but instead to define the sequence according to a limit of sequence identity, e.g. a sequence having a 90% sequence identity to a specified sequence.

Webinars

All webinars
  • Upcoming

In-person event: Festive EPO pharma case law 2025 round-up

Upcoming date: December 17, 2025, 4:00 pm GMT
Join us for a wrap up review of the key pharma EPO caselaw in 2025 and a look ahead to 2026 alongside some mince pies and festive cheer.
  • On-demand

EPO pharma case law 2025: Everything you need to know!

Recorded on: December 12, 2025
Key pharma IP trends, landmark EPO decisions, and strategic advice for IP professionals.
  • On-demand

Securing return of investment: Understanding how large pharma companies think about IP

Recorded on: September 19, 2025
Learn how large pharmaceutical companies think about IP strategy.

Stay connected

Get the latest insights, news, and expert analysis on pharmaceutical IP delivered straight to your inbox.
Subscribe for updates